Search Results - "FRAU, Adolfo"
-
1
Retrospective cost analysis of management of febrile neutropenia in cancer patients in Spain
Published in Current medical research and opinion (01-10-2009)“…Abstract Background: Febrile neutropenia (FN) is associated with disruption of planned chemotherapy and increased management costs. However, the economic…”
Get full text
Journal Article -
2
Docetaxel plus epirubicin is a highly active, well-tolerated, first-line chemotherapy for metastatic breast cancer: results of a large, multicentre phase II study
Published in Cancer chemotherapy and pharmacology (2004)“…In this multicentre phase II study, the efficacy and safety profile of the combination of docetaxel and epirubicin as first-line chemotherapy for metastatic…”
Get full text
Journal Article -
3
Docetaxel plus epirubicin is a highly active, well-tolerated, first-line chemotherapy for metastatic breast cancer: results of a large, multicentre phase II study
Published in Cancer chemotherapy and pharmacology (01-01-2004)“…Purpose: In this multicentre phase II study, the efficacy and safety profile of the combination of docetaxel and epirubicin as first-line chemotherapy for…”
Get full text
Journal Article